References
Cheson BD, Sorensen JM, Vena DA et al (1998) Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine via the Group C protocol mechanism of the National Cancer Institute: a report of 979 patients. J Clin Oncol 16:3007
Nieva J, Bethel K, Saven A (2003) Phase 2 study of rituximab in the treatment of cladribine-failed patients with hairy cell leukemia. Blood 102:810
Leu KM, Ostruszka LJ, Shewach D et al (2004) Laboratory and clinical evidence of synergistic cytotoxicity of sequential treament with gemcitabine followed by docetaxel in the treatment of sarcoma. J Clin Oncol 22:1706
Akashi K, Traver D, Miyamoto T et al (2000) A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature 404:193–197
Feldman AL, Arber DA, Pittaluga S et al (2008) Clonally related follicular lymphomas and histiocytic/dendritic cell sarcomas: evidence for transdifferentiation of the follicular lymphoma clone. Blood 111(12):5433–5439
Feldman AL, Minniti C, Santi M et al (2004) Histiocytic sarcoma after acute lymphoblastic leukaemia: a common clonal origin. Lancet Oncol 5(4):248–250
Zhang D, McGuirk J, Ganguly S et al (2009) Histiocytic/dendritic cell sarcoma arising from follicular lymphoma involving the bone: a case report and review of literature. Int J Hematol 89(4):529–532
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Muslimani, A., Chisti, M.M., Blenc, A.M. et al. Langerhans/dendritic cell sarcoma arising from hairy cell leukemia: a rare phenomenon. Ann Hematol 91, 1485–1487 (2012). https://doi.org/10.1007/s00277-011-1399-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-011-1399-5